SK Bioscience Co Ltd (302440) — Strategic Asset Allocation Index
SK Bioscience Co Ltd (302440) has a Strategic Asset Allocation Index of 16.7% as of September 2022. Strategic assets (PP&E of ₩285.90 Billion plus long-term investments of ₩-) total ₩285.90 Billion, measured against net assets of ₩1.71 Trillion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check SK Bioscience Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
SK Bioscience Co Ltd Strategic Asset Allocation Index (2020–2021)
This chart shows how SK Bioscience Co Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of September 2022, the index stands at 16.7%, representing strategic assets of ₩285.90 Billion against net assets of ₩1.71 Trillion KRW. See SK Bioscience Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for SK Bioscience Co Ltd (2020–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for SK Bioscience Co Ltd from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 302440 company net worth.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 13.8% | ₩220.98 Billion | ₩220.98 Billion | ₩- | ₩1.60 Trillion | ▼ -58.0 pp |
| 2020 | 71.8% | ₩189.48 Billion | ₩189.48 Billion | ₩- | ₩263.79 Billion | — |